Bitte verwenden Sie diesen Link, wenn Sie dieses Dokument zitieren oder verlinken wollen: https://nbn-resolving.org/urn:nbn:de:gbv:9-opus-35986
Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)
| Author: | Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, Roberto Luksch, Victoria Castel, Shifra Ash, Geneviève Laureys, Penelope Brock, Jean Marie Michon, Cormac Owens, Toby Trahair, Godfrey Chi Fung Chan, Ellen Ruud, Henrik Schroeder, Maja Beck-Popovic, Guenter Schreier, Hans Loibner, Peter Ambros, Keith Holmes, Maria Rita Castellani, Mark N. Gaze, Alberto Garaventa, Andrew D.J. Pearson, Holger N. LodeORCiD |
|---|---|
| URN: | urn:nbn:de:gbv:9-opus-35986 |
| DOI: | https://doi.org/10.3390/cancers12020309 |
| ISSN: | 2072-6694 |
| Parent Title (English): | Cancers |
| Publisher: | MDPI |
| Document Type: | Article |
| Language: | English |
| Date of first Publication: | 2020/01/28 |
| Release Date: | 2020/10/14 |
| Tag: | dinutuximab beta; high-risk neuroblastoma; immunotherapy |
| GND Keyword: | - |
| Volume: | 12 |
| Issue: | 2 |
| Faculties: | Universitätsmedizin / Klinik und Poliklinik für Kinder- und Jugendmedizin |
| Licence (German): |  Creative Commons - Namensnennung |